SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Kosan BioSciences -- KOSN
An SI Board Since May 2001
Posts SubjectMarks Bans Symbol
933 40 0 KOSN
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
233>> When will the market reward the business progress being made here? <scaram(o)uche-3/28/2003
232Rick or anyone, Did they give any hints as to timing of commencement of EpoD PItuck-3/28/2003
231not if the guess was comming from u :-) cheers Stefaandalroi-3/26/2003
230Wouldn't a bad guess be worse than no guess at all? ;-) The JNJ deal involscaram(o)uche-3/26/2003
229Rick any idea about what amount they are talking , guess ??? anyway think thisdalroi-3/26/2003
228Kosan Antibiotic Compound Meets Johnson & Johnson Pharmaceutical Research &ascaram(o)uche-3/26/2003
227Thanks! Slides were not visible when I checked last night, but that was 3 a.m.,scaram(o)uche-3/19/2003
226Rick per kosan website the slides are visible audio is beeing archived Cheers dalroi-3/19/2003
225arrrrrrrrrrrrrrrrrrgh............. they took down the link............ media.cscaram(o)uche-3/19/2003
224"currently finishing off material for phase II" (SG Cowen, re. epoD) scaram(o)uche-3/18/2003
223From Conforma Therapetuics web-site: Ansamycins-Based HSP90 Modulators Two dikeokalani'nui-3/11/2003
222A garbled version of this (meshed with GNVC's quarterly PR) came out earliertuck-3/11/2003
221HAYWARD, Calif., March 4 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporatenigel bates-3/4/2003
220750K...... makes a real difference. Ticks me off when companies get arrogant scaram(o)uche-2/27/2003
219HAYWARD, Calif., Feb. 27 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporatenigel bates-2/27/2003
218>>Didn't we have a private discussion about antibiotics not too long akeokalani'nui-2/7/2003
217Didn't we have a private discussion about antibiotics not too long ago? Postuck-2/7/2003
216J Am Chem Soc 2003 Jan 8;125(1):26-7 Links Conformation-activity relationshipkeokalani'nui-2/5/2003
215Same questions that I have, but note that it says forward "in" preclinscaram(o)uche-1/14/2003
214Kosan Extends Collaboration Agreement for Production of Novel Antibiotic Leads TIcebrg-1/14/2003
213From Y! HSP90 Inhibitor presentation by: gandalf2325 Long-Term Sentiment: Buy keokalani'nui-1/13/2003
212Maybe JnJ will step up now. I think it will, but it isn't likely to be a bikeokalani'nui-1/9/2003
211Well, here we are almost at the end of December . . . >>Anyhow, the tuck-12/28/2002
210You can't ask too much of C.K., after all he works with dirty hands.<g>Jibacoa-12/27/2002
209That reminds me. Been meaning to post the ASH 17-AAC/velcade abstracts--there akeokalani'nui-12/21/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News